Cancer Extravasation Dynamics in an In Vitro Blood Vessel Model

Video   Oct 18, 2016

 

Extravasation of cancer cells from the blood vessel, which involves the trans-endothelial migration and tissue invasion, remains a less well understood process in cancer metastasis [1]. Understanding the mechanisms underlying the extravasation process is of fundamental importance in developing therapeutic targets for the prevention of metastasis [2],[3]. The aim of this research is to investigate breast cancer extravasation in vitro, using a microfluidic system with adjustable biophysical and biochemical factors, to mimic the 3D in vivo vascular microenvironment. In particular, the device is fabricated to mimic the interface between the blood vessel wall and the surrounding extracellular matrix. Using this microfluidic system, breast cancer cell extravasation from the blood vessel to the artificially simulated extracellular matrix was observed. Combining this microfluidic platform with an automated image analysis algorithm, cancer cell morphological changes during the migration process were quantified and they were found to be microenvironment-dependent. In particular, cancer cells were observed to exhibit invadopodia-like protrusions during the invasion process and the presence of endothelial cells forming the vessel lumen was found to sustain the cancer cell invasion into the matrix.

 
 
 
 

Recommended Videos

The Role of Proteogenomics in Cancer Research

Video

Proteomics is the comprehensive study of the complete set of proteins in an organism (called the proteome). Analyzing the proteome of a patient’s cancer can also provide information on how to best diagnose and treat the patient.

WATCH NOW

Killing Cancer Cells with the Help of Infrared Light

Video

Near-infrared photoimmunotherapy uses an antibody–photoabsorber conjugate that binds to cancer cells. When near-infrared light is applied, the cells swell and then burst, causing the cancer cell to die.

WATCH NOW

Contrasting LBAs and LC-MS for Peptide and Protein Bioanalysis

Video

Kelly Doering discusses ligand binding assays (LBAs) and compares the advantages and limitations of this technology to LC-MS.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE